Concepedia

Mayra García-Carmenate

MG

3

Publications

105

Citations

3

H-Index

2021

Active since

Affiliations

Cuban Neuroscience Center(Current)

Finlay Institute

Pasteur Institute of Iran

Instituto de Medicina Tropical “Pedro Kourí”

Ghent University

Mayra García-Carmenate is an author at Cuban Neuroscience Center specializing in vaccine development, vaccine safety, and vaccination.

ORCID

Top concepts

Publications per year

2021–2022

3

Publications

3

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial

María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela‐Silva et al. · The Lancet Regional Health - Americas · 2022 · 44 citations · Full text

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial

María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela‐Silva et al. · 2021 · 31 citations · Full text

, , +20

Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults

María Eugenia Toledo-Romaní, Mayra García-Carmenate, Leslyhana Verdecia-Sánchez et al. · Med · 2022 · 30 citations · Full text

, , +6

Rows per page

1–3 of 3